PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - Schwartz, Gregory G.
TI  - Dalcetrapib in Patients with Recent Acute Coronary Syndrome
DP  - 2012  01
TA  - MD Conference Express
PG  - 20--21
VI  - 12
IP  - 18
4099  - http://mdc.sagepub.com/content/12/18/20.short
4100  - http://mdc.sagepub.com/content/12/18/20.full
AB  - Observational studies have suggested that spontaneously higher high-density lipoprotein cholesterol (HDL-C) levels are associated with lower cardiovascular (CV) risk; however, it is uncertain whether raising HDL-C by a pharmacologic approach reduces the risk. The objective of the Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome [dal-OUTCOMES; NCT00658515; Schwartz GG et al. N Engl J Med 2012] was to compare the effects of dalcetrapib versus placebo in patients with recent acute coronary syndrome.